Understanding neuroinflammation: Exploring the potential of iPSC-derived microglia for disease Modeling and drug discovery

Microglia are becoming an increasingly crucial component of in vitro neurodegenerative disease research. This webinar will explore the vital topic of understanding neuroinflammation, focusing on human iPSC-derived microglia for disease modeling and compound screening relevant to humans.

Featuring engaging discussion topics, compelling functional data, and expert insights, this webinar is a must-see for anyone looking to harness the power of iPSC-derived microglia for research and drug discovery.

Key highlights

• The growing importance of microglia in modeling neurodegenerative diseases
• Insights into the functional data behind axoCells iPSC-derived microglia
• How collaborative efforts with biopharma are contributing to the development of effective microglia-based disease models
• Strategies for microglia compound screening initiatives

Featured product

axoCells™ Human iPSC-Derived Microglia, male donor, ≥1 million cells

axoCells Human iPSC-Derived Microglia (≥1 million cells) for neuroscience research. Microglia made from iPSCs generated from a 40-50-year-old male donor's fibroblasts.

About the speaker

Dr. Jess Tilman, Principal Scientist and Microglia Expert

Get access now